Drugs / Magnesium glucoheptonate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07173855 | Nov 2025 → Mar 2027 expected | — | Scarborough General Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Magnesium glucoheptonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07173855 ↗ |
| Route | Oral | “Magnesium glucoheptonate 30mL po q12h x 2 is an oral option” NCT07173855 ↗ |